28 related articles for article (PubMed ID: 1836999)
1. Aspirin in essential thrombocythemia. For whom? What formulation? What regimen?
Cattaneo M
Haematologica; 2023 Jun; 108(6):1487-1499. PubMed ID: 36632735
[TBL] [Abstract][Full Text] [Related]
2. The Relationship between Type 2 Diabetes and Platelet Indicators.
Chen X; Fang L; Lin H; Shen P; Zhang T; Li H; Li X; Yu M; Xu C; Zhang J; Lu F; DU X; Hu R; Zhong J
Iran J Public Health; 2017 Sep; 46(9):1211-1216. PubMed ID: 29026786
[TBL] [Abstract][Full Text] [Related]
3. Thrombocytosis in 715 Dogs (2011-2015).
Woolcock AD; Keenan A; Cheung C; Christian JA; Moore GE
J Vet Intern Med; 2017 Nov; 31(6):1691-1699. PubMed ID: 28895208
[TBL] [Abstract][Full Text] [Related]
4. Markers of endothelial and in vivo platelet activation in patients with essential thrombocythemia and polycythemia vera.
Karakantza M; Giannakoulas NC; Zikos P; Sakellaropoulos G; Kouraklis A; Aktypi A; Metallinos IC; Theodori E; Zoumbos NC; Maniatis A
Int J Hematol; 2004 Apr; 79(3):253-9. PubMed ID: 15168594
[TBL] [Abstract][Full Text] [Related]
5. Abnormal typical pattern of platelet function and thromboxane generation in unstable angina.
Zahavi M; Zahavi J; Schafer R; Firsteter E; Laniado S
Thromb Haemost; 1989 Nov; 62(3):840-5. PubMed ID: 2531938
[TBL] [Abstract][Full Text] [Related]
6. Enhanced platelet release reaction, shortened platelet survival time and increased platelet aggregation and plasma thromboxane B2 in chronic obstructive arterial disease.
Zahavi J; Zahavi M
Thromb Haemost; 1985 Feb; 53(1):105-9. PubMed ID: 3158092
[TBL] [Abstract][Full Text] [Related]
7. Thromboxane-dependent platelet activation in vivo precedes arterial thrombosis in thrombocythaemia: a rationale for the use of low-dose aspirin as an antithrombotic agent.
van Genderen PJ; Prins FJ; Michiels JJ; Schrör K
Br J Haematol; 1999 Mar; 104(3):438-41. PubMed ID: 10086775
[TBL] [Abstract][Full Text] [Related]
8. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
[TBL] [Abstract][Full Text] [Related]
9. An abnormal pattern of multiple platelet function abnormalities and increased thromboxane generation in patients with primary thrombocytosis and thrombotic complications.
Zahavi J; Zahavi M; Firsteter E; Frish B; Turleanu R; Rachmani R
Eur J Haematol; 1991 Nov; 47(5):326-32. PubMed ID: 1836999
[TBL] [Abstract][Full Text] [Related]
10. Platelet-mediated microvascular inflammation and thrombosis in thrombocythemia vera: a distinct aspirin-responsive arterial thrombophilia, which transforms into a bleeding diathesis at increasing platelet counts.
Michiels JJ
Pathol Biol (Paris); 2003 Apr; 51(3):167-75. PubMed ID: 12781799
[TBL] [Abstract][Full Text] [Related]
11. Clinical and laboratory features, pathobiology of platelet-mediated thrombosis and bleeding complications, and the molecular etiology of essential thrombocythemia and polycythemia vera: therapeutic implications.
Michiels JJ; Berneman Z; Van Bockstaele D; van der Planken M; De Raeve H; Schroyens W
Semin Thromb Hemost; 2006 Apr; 32(3):174-207. PubMed ID: 16673274
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
